352 related articles for article (PubMed ID: 23515283)
1. Clusterin decreases hepatic SREBP-1c expression and lipid accumulation.
Seo HY; Kim MK; Jung YA; Jang BK; Yoo EK; Park KG; Lee IK
Endocrinology; 2013 May; 154(5):1722-30. PubMed ID: 23515283
[TBL] [Abstract][Full Text] [Related]
2. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
5. Hepatic TRAP80 selectively regulates lipogenic activity of liver X receptor.
Kim GH; Oh GS; Yoon J; Lee GG; Lee KU; Kim SW
J Clin Invest; 2015 Jan; 125(1):183-93. PubMed ID: 25437875
[TBL] [Abstract][Full Text] [Related]
6. cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis.
Min AK; Jeong JY; Go Y; Choi YK; Kim YD; Lee IK; Park KG
Diabetologia; 2013 Feb; 56(2):412-22. PubMed ID: 23150180
[TBL] [Abstract][Full Text] [Related]
7. 2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed mice.
Zhang J; Zhang LN; Chen DM; Fu YY; Zhang F; Yang LL; Xia CM; Jiang HW; Tang CL; Xie ZF; Yang F; Li J; Tang J; Li JY
Acta Pharmacol Sin; 2015 Apr; 36(4):483-96. PubMed ID: 25832429
[TBL] [Abstract][Full Text] [Related]
8. The E-box-like sterol regulatory element mediates the insulin-stimulated expression of hepatic clusterin.
Oh GS; Kim G; Yoon J; Kim GH; Kim SW
Biochem Biophys Res Commun; 2015 Sep; 465(3):501-6. PubMed ID: 26282207
[TBL] [Abstract][Full Text] [Related]
9. The Hexane Fraction of cyperus rotundus Prevents Non-Alcoholic Fatty Liver Disease Through the Inhibition of Liver X Receptor α-Mediated Activation of Sterol Regulatory Element Binding Protein-1c.
Oh GS; Yoon J; Lee GG; Kwak JH; Kim SW
Am J Chin Med; 2015; 43(3):477-94. PubMed ID: 25967664
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
Ferré P; Foufelle F
Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
[TBL] [Abstract][Full Text] [Related]
11. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
Wu J; Wang C; Li S; Li S; Wang W; Li J; Chi Y; Yang H; Kong X; Zhou Y; Dong C; Wang F; Xu G; Yang J; Gustafsson JÅ; Guan Y
Hepatology; 2013 Aug; 58(2):617-28. PubMed ID: 23348573
[TBL] [Abstract][Full Text] [Related]
13. Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes.
Yin HQ; Kim YC; Chung YS; Kim YC; Shin YK; Lee BH
Toxicol Appl Pharmacol; 2009 Apr; 236(1):124-30. PubMed ID: 19371623
[TBL] [Abstract][Full Text] [Related]
14. Consumption of soy protein isolate reduces hepatic SREBP-1c and lipogenic gene expression in wild-type mice, but not in FXR-deficient mice.
Hashidume T; Sasaki T; Inoue J; Sato R
Biosci Biotechnol Biochem; 2011; 75(9):1702-7. PubMed ID: 21897047
[TBL] [Abstract][Full Text] [Related]
15. Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism.
Yang M; Liang Z; Yang M; Jia Y; Yang G; He Y; Li X; Gu HF; Zheng H; Zhu Z; Li L
FASEB J; 2019 Sep; 33(9):10077-10088. PubMed ID: 31237775
[TBL] [Abstract][Full Text] [Related]
16. Deoxypodophyllotoxin in Anthriscus sylvestris alleviates fat accumulation in the liver via AMP-activated protein kinase, impeding SREBP-1c signal.
Kim KY; Park KI; Lee SG; Baek SY; Lee EH; Kim SC; Kim SH; Park SG; Yu SN; Oh TW; Kim JH; Kim KJ; Ahn SC; Kim YW
Chem Biol Interact; 2018 Oct; 294():151-157. PubMed ID: 30148990
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of LXRα-dependent steatosis and oxidative injury by liquiritigenin, a licorice flavonoid, as mediated with Nrf2 activation.
Kim YW; Kim YM; Yang YM; Kay HY; Kim WD; Lee JW; Hwang SJ; Kim SG
Antioxid Redox Signal; 2011 Mar; 14(5):733-45. PubMed ID: 20677908
[TBL] [Abstract][Full Text] [Related]
18. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice.
Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT
Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913
[TBL] [Abstract][Full Text] [Related]
19. Genipin alleviates high-fat diet-induced hyperlipidemia and hepatic lipid accumulation in mice via miR-142a-5p/SREBP-1c axis.
Zhong H; Chen K; Feng M; Shao W; Wu J; Chen K; Liang T; Liu C
FEBS J; 2018 Feb; 285(3):501-517. PubMed ID: 29197188
[TBL] [Abstract][Full Text] [Related]
20. Hepatic differentiated embryo-chondrocyte-expressed gene 1 (Dec1) inhibits sterol regulatory element-binding protein-1c (Srebp-1c) expression and alleviates fatty liver phenotype.
Shen L; Cui A; Xue Y; Cui Y; Dong X; Gao Y; Yang H; Fang F; Chang Y
J Biol Chem; 2014 Aug; 289(34):23332-42. PubMed ID: 24993831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
